PD180970은 p210Bcr-Abl의 자가 인산화를 억제하는 IC50이 5 nM인 매우 강력하고 ATP와 경쟁하는 p210Bcr-Abl 키나아제 억제제입니다. PD180970은 또한 각각 0.8nm와 50nm의 IC50으로 Src 및 KIT 키나아제를 억제합니다. PD180970은 K562 백혈병 세포의 세포 사멸을 유도하며 만성 골수성 백혈병 연구에 사용될 수 있습니다.
사양
동의어
PD 180970 | Linrodostat(BMS-986205) | PD180970 | PD-180970 | (2S)-2-((2R,3S,4R,5R)-(5-(4-Aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy)phenoxy-(S)-phosphorylamino)propionic acid 2-ethyl-butyl ester | 6-(2,6-dichlorophenyl)-2-(4-fluoro-3-methyl-anilino)-8-methyl-pyrido[2,3-d]pyrimidin-7-one | 6- Show more
사양 및 순도
≥98%(HPLC)
생화학 및 생리적 메커니즘
ATP-competitive inhibitor of p210bcr/abltyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibitsin vivotyrosine phosphorylation of Gab2, CrkL and p210bcr/abl(IC50values are 80, 80 and 170 nM respectively). Potently inhibits p210bcr/ablautophosphorylationin vitro(IC50= 5 nM). Also potently inhibits c-Src and KIT (IC50values are 0.8 and 50 nM, respectively). Induces autophagy and reduces neuroinflammation in animal models of Parkinson's disease.PD-180970 is a potent inhibitor of the p210 Bcr-Abl tyrosine kinase.
This compound belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.